Table 1.
Clinical characteristics of screened gynecologic cancer patients.
| Clinical Factor | N, % |
|---|---|
| Primary Gynecologic Cancer Site | |
| Ovarian/Fallopian tube/primary peritoneal | 170 (34.5 %) |
| Endometrial | 156 (31.7 %) |
| Cervical | 119 (24.2 %) |
| Vaginal/Vulvar | 24 (4.9 %) |
| Unknown |
23 (4.7 %) |
| Stage | |
| I | 142 (28.9 %) |
| II | 46 (9.3 %) |
| III | 108 (22 %) |
| IV | 136 (27.6 %) |
| Unknown |
60 (12.2 %) |
| Cancer Status | |
| Primary | 369 (75 %) |
| Recurrent/Progressive | 52 (10.6 %) |
| Unknown |
71 (14.4 %) |
| Histology | |
| Adenocarcinoma | 174 (35.4 %) |
| Squamous cell | 66 (13.4 %) |
| Endometrioid | 105 (21.3 %) |
| Serous | 48 (9.8 %) |
| Clear cell | 16 (3.3 %) |
| Mucinous | 2 (0.4 %) |
| Mixed | 12 (2.4 %) |
| Unknown |
69 (14 %) |
| Patient Status | |
| New | 395 (80.3 %) |
| Established | 79 (16 %) |
| Unknown | 18 (3.7 %) |